Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
The ACE up their sleeves: A decoy trick to divert the virus, make COVID milder
+Print Archive
News
The ACE up their sleeves: A decoy trick to divert the virus, make COVID milder
Wednesday 17 June 2020, 12:15 AM

Immunologist and researcher Rohan Ameratunga
Rohan Ameratunga and fellow researchers hope to make an effective COVID-19 inhaler medicine based on a key enzyme where the virus starts its damaging
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Ameratunga R, Lehnert K, Leung E, et al. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. NZ Med J 2020;133(1515):112–18.